These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8515598)
1. [Interleukin-1 beta production by alveolar macrophages in cases of asbestos exposure]. Tokuyama T; Yoneda T; Tamura M; Tsukaguchi K; Yoshikawa M; Tou R; Narita N; Kasuga H; Miyazaki R Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Feb; 31(2):193-8. PubMed ID: 8515598 [TBL] [Abstract][Full Text] [Related]
2. [Tumor necrosis factor alpha in bronchoalveolar lavage fluid and its production by alveolar macrophages with asbestos exposure]. Tokuyama T; Yoneda T; Tsukaguchi K; Yoshikawa M; Fu A; Tomoda K; Nakaya M; Narita N; Tamura M; Miyazaki R Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Mar; 32(3):205-10. PubMed ID: 8189639 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast mitogens in bronchoalveolar lavage (BAL) fluid from asbestos-exposed subjects with and without clinical evidence of asbestosis: no evidence for the role of PDGF, TNF-alpha, IGF-1, or IL-1 beta. Mutsaers SE; Harrison NK; McAnulty RJ; Liao JY; Laurent GJ; Musk AW J Pathol; 1998 Jun; 185(2):199-203. PubMed ID: 9713348 [TBL] [Abstract][Full Text] [Related]
4. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. Zhang Y; Lee TC; Guillemin B; Yu MC; Rom WN J Immunol; 1993 May; 150(9):4188-96. PubMed ID: 8473757 [TBL] [Abstract][Full Text] [Related]
5. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4. Garcia JG; Griffith DE; Cohen AB; Callahan KS Am Rev Respir Dis; 1989 Jun; 139(6):1494-501. PubMed ID: 2543249 [TBL] [Abstract][Full Text] [Related]
6. Additional NO2 exposure induces a decrease in cytokine specific mRNA expression and cytokine release of particle and fibre exposed human alveolar macrophages. Drumm K; Buhl R; Kienast K Eur J Med Res; 1999 Feb; 4(2):59-66. PubMed ID: 10066641 [TBL] [Abstract][Full Text] [Related]
7. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Kline JN; Schwartz DA; Monick MM; Floerchinger CS; Hunninghake GW Chest; 1993 Jul; 104(1):47-53. PubMed ID: 8325116 [TBL] [Abstract][Full Text] [Related]
8. Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos. Brunetti G; Delmastro M; Fonte R; Moscato G; Bossi A; Baiardi P; Massola A; Meloni F G Ital Med Lav Ergon; 2003; 25(2):152-60. PubMed ID: 12872499 [TBL] [Abstract][Full Text] [Related]
9. [Cytoimmunological changes in the bronchoalveolar lavage in asbestos exposure patients]. Gil K Folia Med Cracov; 2006; 47(1-4):21-36. PubMed ID: 18038610 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290 [TBL] [Abstract][Full Text] [Related]
11. [Morphometry of alveolar macrophages]. Gil K; Soja J; Zieba-Nytko E Folia Med Cracov; 2007; 48(1-4):15-21. PubMed ID: 19051689 [TBL] [Abstract][Full Text] [Related]
12. [The clinical utility of asbestos body counts in bronchoalveolar lavage fluid]. Takabe K; Tsukada Y; Shimizu T; Takagiwa J; Hirayama M; Nakayama M; Miura H; Akabane H; Takayama S; Aida S Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1196-204. PubMed ID: 9493446 [TBL] [Abstract][Full Text] [Related]
13. Influence of cigarette smoking on bronchoalveolar lavage cellularity in asbestos-induced lung disease. Schwartz DA; Galvin JR; Merchant RK; Dayton CS; Burmeister LF; Merchant JA; Hunninghake GW Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):400-5. PubMed ID: 1736749 [TBL] [Abstract][Full Text] [Related]
14. Increased alveolar plasminogen activator in early asbestosis. Cantin A; Allard C; Bégin R Am Rev Respir Dis; 1989 Mar; 139(3):604-9. PubMed ID: 2923358 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotactic factor release and neutrophil alveolitis in asbestos-exposed individuals. Hayes AA; Rose AH; Musk AW; Robinson BW Chest; 1988 Sep; 94(3):521-5. PubMed ID: 3044701 [TBL] [Abstract][Full Text] [Related]
16. Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients. Haku T; Yanagawa H; Ohmoto Y; Takeuchi E; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Sone S Oncol Res; 1996; 8(12):519-26. PubMed ID: 9160356 [TBL] [Abstract][Full Text] [Related]
17. Cultured alveolar macrophages from patients with idiopathic pulmonary fibrosis (IPF) show dysregulation of lipopolysaccharide-induced tumor necrosis factor-alpha (TNF-alpha) and interleukin-10 (IL-10) inductions. Freeburn RW; Armstrong L; Millar AB Eur Cytokine Netw; 2005; 16(1):5-16. PubMed ID: 15809201 [TBL] [Abstract][Full Text] [Related]
18. Correlation of bronchoalveolar lavage and clinical and functional findings in asbestosis. Xaubet A; Rodriguez-Roisín R; Bombí JA; Marín A; Roca J; Agustí-Vidal A Am Rev Respir Dis; 1986 May; 133(5):848-54. PubMed ID: 3706896 [TBL] [Abstract][Full Text] [Related]
19. Inhalation of toluene diisocyanate is associated with increased production of nitric oxide by rat bronchoalveolar lavage cells. Huffman LJ; Judy DJ; Frazer D; Shapiro RE; Castranova V; Billie M; Dedhia HV Toxicol Appl Pharmacol; 1997 Jul; 145(1):61-7. PubMed ID: 9221824 [TBL] [Abstract][Full Text] [Related]